Related Experiment Video
Updated: Apr 25, 2026

09:26
Disruption of Frontal Lobe Neural Synchrony During Cognitive Control by Alcohol Intoxication
Published on: February 6, 2019
17.3K
High-dose alcohol intoxication differentially modulates cognitive subprocesses involved in response inhibition
Ann-Kathrin Stock1,2, Tom Schulz1,2, Martin Lenhardt1,2
1Institute for Cognitive Neuroscience, Biopsychology, Ruhr-University Bochum, Germany.
Addiction Biology
|August 19, 2014
Summary
High-dose alcohol intoxication impairs response inhibition by affecting specific brain pathways. This study reveals alcohol selectively impacts motor inhibition and evaluation, not pre-motor inhibition, highlighting targeted neurophysiological changes.
Area of Science:
- Neuroscience
- Psychopharmacology
- Cognitive Psychology
Background:
- High-dose alcohol intoxication, or binge drinking, is linked to social and legal issues due to impaired response inhibition.
- The neurophysiological mechanisms underlying alcohol-induced disinhibition remain poorly understood, despite extensive behavioral research.
- Understanding these mechanisms is crucial for addressing the consequences of impaired decision-making under alcohol influence.
Purpose of the Study:
- To investigate the specific subprocesses of response inhibition affected by high-dose alcohol intoxication.
- To differentiate the impact of alcohol on distinct neural pathways involved in inhibitory control.
- To elucidate the role of dopaminergic signaling in alcohol's effects on response inhibition.
Main Methods:
- A within-subject design was employed with 27 healthy young participants.
- Participants completed a GO/NOGO task in both sober and intoxicated (approx. 1.2‰ BAC) states.
- Behavioral data and event-related potentials (ERPs), specifically N2 and NOGO-P3 components, were recorded.
Main Results:
- Alcohol intoxication significantly altered the NOGO-P3 component, associated with motor inhibition and evaluation via mesocorticolimbic pathways.
- The N2 component, linked to pre-motor inhibition via nigrostriatal dopamine pathways, remained unaffected by alcohol.
- Alcohol's effects were most pronounced when automated stimulus-response mapping processes were disrupted during inhibition.
Conclusions:
- Alcohol-induced changes in dopaminergic neurotransmission do not globally impair response inhibition.
- The effects are specific to subprocesses, primarily targeting mesocorticolimbic pathways involved in motor inhibition.
- This suggests alcohol selectively disrupts higher-level inhibitory control rather than basic pre-motor inhibition mechanisms.
Related Concept Videos
CNS Depressants: Alcohol and Nicotine
1.6K
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
1.6K
Depressants
659
Depressant drugs, including alcohol and sedative-hypnotics, diminish central nervous system activity by enhancing the action of gamma-aminobutyric acid (GABA), a neurotransmitter that reduces brain activity and promotes relaxation. These substances can have various therapeutic uses but also pose significant risks, especially when misused or combined.
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
659
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
911
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
911

